Related Experiment Video
Updated: Jul 29, 2026
Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
Synoptic reporting : Chances and challenges for secondary use of pathology data in biobanking
1Core Facility Biobank, Medical Faculty University Tübingen, Otfried-Müller-Straße 37, 72076, Tübingen, Germany. Julian.doerenberg@med.uni-tuebingen.de.
Background:
A high quality of biosample-associated data (DQ) is critical for biomedical research. Synoptic reporting (SR) provides the chance to increase DQ for the secondary use of data from surgical pathology (SP) in Germany. Hence, it is of high interest for biobanks that data-providing SP departments force the implementation of SR.
Materials And Methods:
Synoptic reporting is already implemented in some use cases [1]. Recommendations for how to proceed are available [2-4]. Central efforts-such as the DGP's AG Semantik-are carried out to support standardisation in SR.
Results:
Successful use of SR requires efforts from SP departments as well as from biobanks. Firstly, it requires revision of processes in SP departments. This also applies to the similar tissue assessment processes in biobanks. Secondly, biobanks need to prepare by implementing the required standards such as FHIR and SNOMED CT.
Conclusion:
Common efforts in SP departments and biobanks are required to facilitate the utmost benefits of SR for DQ in patient care and research. Biobanks can serve as a platform for SP departments to attempt new processes that implement SR and can provide independent feedback on DQ in SP departments.
